Careview Communications (OTCMKTS:CRVW – Get Free Report) and iRhythm Technologies (NASDAQ:IRTC – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
Valuation and Earnings
This table compares Careview Communications and iRhythm Technologies”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Careview Communications | $8.25 million | N/A | -$4.70 million | N/A | N/A |
| iRhythm Technologies | $591.84 million | 8.60 | -$113.29 million | ($2.93) | -54.10 |
Analyst Ratings
This is a summary of current recommendations for Careview Communications and iRhythm Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Careview Communications | 0 | 0 | 0 | 0 | 0.00 |
| iRhythm Technologies | 0 | 1 | 9 | 1 | 3.00 |
iRhythm Technologies has a consensus target price of $157.30, suggesting a potential downside of 0.76%. Given iRhythm Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Careview Communications.
Risk and Volatility
Careview Communications has a beta of -0.21, meaning that its share price is 121% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.
Profitability
This table compares Careview Communications and iRhythm Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Careview Communications | -55.51% | N/A | -110.03% |
| iRhythm Technologies | -14.06% | -90.03% | -8.52% |
Summary
iRhythm Technologies beats Careview Communications on 8 of the 10 factors compared between the two stocks.
About Careview Communications
CareView Communications, Inc. provides video monitoring solutions in the United States. Its products include CareView Patient Safety System, a video monitoring tool to improve the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; and CareView Connect, which provides resident monitoring products and services for the long- term care industry; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system that provides a suite of hardware and software to facilitate a data-driven solution for alert management and monitoring. The company also offers Caregiver Platform that offers caregiver connect mobile application to provide a convenient and intuitive interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. In addition, it provides SitterView and TeleMedView that allows hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. is based in Lewisville, Texas.
About iRhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Receive News & Ratings for Careview Communications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Careview Communications and related companies with MarketBeat.com's FREE daily email newsletter.
